Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
-0.01 (-3.39%)
as of Jan 22, 2020

Last 0.34
Change -0.01 (-3.39%)
Open 0.35
Prev. Close 0.35
Today's Range
0.33
0.35
52wk Range
0.23
2.50
Volume 3,859,200
Avg Volume 12,053,150
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
BIOC -3.39% -49.30% -82.46%
DJIA -0.03% +5.46% +19.59%
S&P 500 +0.03% +7.67% +26.16%

Key Statistics

Annual EPS -2.67
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 16,860
Weighted Alpha -69.98
Standard Deviation -0.48
Profit Margin 3.63%
Beta 1.56

Growth Rates

YTD +19.58%
1-Year -82.37%
3-Year -99.27%
5-Year -99.82%

Opinion

Sell Hold Buy

Recent Headlines

Biocept Announces Validation and Availability of its

PR Newswire via COMTEX - Tue Jan 14, 08:05AM EST
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that its(full story)
BIOC: 0.34 (-0.01)

Biocept, Inc. Awarded United States Patent for the Use

PR Newswire via COMTEX - Wed Jan 08, 09:00AM EST
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.34 (-0.01)

Biocept Announces Closing of $10.0 Million

PR Newswire via COMTEX - Thu Dec 12, 08:00AM EST
Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy solutions, today announced that on December 11, 2019 it closed its previously announced underwritten public offering of 24,6(full story)
BIOC: 0.34 (-0.01)

Biocept Announces Pricing of $10.0 Million

PR Newswire via COMTEX - Mon Dec 09, 09:15AM EST
Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy solutions, today announced the pricing of an underwritten public offering of 24,600,000 shares of its common stock (or pre-f(full story)
BIOC: 0.34 (-0.01)

Biocept's Liquid Biopsy CTC Testing for Breast Cancer

PR Newswire via COMTEX - Tue Dec 03, 08:05AM EST
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that cli(full story)
BIOC: 0.34 (-0.01)